Biohaven Ltd (NYSE: BHVN) kicked off on Friday, down -3.22% from the previous trading day, before settling in for the closing price of $15.23. Over the past 52 weeks, BHVN has traded in a range of $12.79-$55.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -49.78%. While this was happening, its average annual earnings per share was recorded 16.89%. With a float of $89.17 million, this company’s outstanding shares have now reached $102.10 million.
Let’s determine the extent of company efficiency that accounts for 256 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Biohaven Ltd (BHVN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Biohaven Ltd is 12.68%, while institutional ownership is 86.31%. The most recent insider transaction that took place on Mar 04 ’25, was worth 996,238. In this transaction Director of this company bought 32,700 shares at a rate of $30.47, taking the stock ownership to the 2,320,571 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director bought 29,000 for $35.94, making the entire transaction worth $1,042,393. This insider now owns 2,368,741 shares in total.
Biohaven Ltd (BHVN) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -3.5 earnings per share (EPS), lower than consensus estimate (set at -1.7) by -1.8. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.05% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Take a look at Biohaven Ltd’s (BHVN) current performance indicators. Last quarter, stock had a quick ratio of 2.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.37, a number that is poised to hit -1.90 in the next quarter and is forecasted to reach -6.36 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Looking closely at Biohaven Ltd (NYSE: BHVN), its last 5-days average volume was 1.55 million, which is a drop from its year-to-date volume of 1.67 million. As of the previous 9 days, the stock’s Stochastic %D was 69.16%.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 10.60%, which indicates a significant decrease from 60.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.82 in the past 14 days, which was lower than the 1.31 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.70, while its 200-day Moving Average is $29.46. However, in the short run, Biohaven Ltd’s stock first resistance to watch stands at $15.34. Second resistance stands at $15.93. The third major resistance level sits at $16.59. If the price goes on to break the first support level at $14.08, it is likely to go to the next support level at $13.42. Should the price break the second support level, the third support level stands at $12.83.
Biohaven Ltd (NYSE: BHVN) Key Stats
The company with the Market Capitalisation of 1.51 billion has total of 102,113K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -846,420 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -221,680 K.
